[Interpretation of the UK screening and treatment of retinopathy of prematurity updated 2022 guidelines]. / è±å½æ©äº§å¿è§ç½èç
åççæ¥åæ²»çæå2022æ´æ°ç解读.
Zhongguo Dang Dai Er Ke Za Zhi
; 26(5): 437-443, 2024 May 15.
Article
in Zh
| MEDLINE
| ID: mdl-38802901
ABSTRACT
The UK screening and treatment of retinopathy of prematurity (ROP) updated 2022 guidelines were developed by a multidisciplinary guideline development group from the Royal College of Paediatrics and Child Health and the Royal College of Ophthalmologists, following the standards of the National Institute for Health and Care Excellence. They were published on the websites of the Royal College of Paediatrics and Child Health and the Royal College of Ophthalmologists in March 2022, and formally published in Early Human Development in March 2023. The guidelines provide evidence-based recommendations for the screening and treatment of ROP. The most significant change in the 2022 updated version compared to the previous guidelines is the lowering of the gestational age screening criterion to below 31 weeks. The treatment section covers treatment indications, timing, methods, and follow-up visits of ROP. This article interprets the guidelines and compares them with ROP guidelines/consensus in China, providing a reference for domestic peers.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Retinopathy of Prematurity
/
Practice Guidelines as Topic
Limits:
Humans
/
Newborn
Country/Region as subject:
Europa
Language:
Zh
Journal:
Zhongguo Dang Dai Er Ke Za Zhi
Year:
2024
Document type:
Article